Literature DB >> 9858282

In vivo echo-planar imaging of rat spinal cord.

D A Fenyes1, P A Narayana.   

Abstract

An integrated approach to echo-planar imaging of rat spinal cord in vivo with a small field of view (FOV) is presented. This protocol is based on a multishot interleaved echo-planar imaging (EPI) sequence and includes: 1) use of an inductively coupled implantable coil for improved signal-to-noise ratio (SNR); 2) three-dimensional (3D) automatic shimming of the magnetic field over the spinal cord; and 3) post-acquisition data processing using a multireference scan for minimizing image artifacts. Some of the practical issues in implementing this protocol are discussed. This imaging protocol will be useful in characterizing the spinal cord pathology using techniques that are otherwise time-consuming, such as diffusion tensor imaging.

Entities:  

Mesh:

Year:  1998        PMID: 9858282     DOI: 10.1016/s0730-725x(98)00093-9

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  10 in total

1.  In vivo longitudinal MRI and behavioral studies in experimental spinal cord injury.

Authors:  Laura M Sundberg; Juan J Herrera; Ponnada A Narayana
Journal:  J Neurotrauma       Date:  2010-10-09       Impact factor: 5.269

2.  Diffusion tractography of the cervical spinal cord by using parallel imaging.

Authors:  Kazuhiro Tsuchiya; Akira Fujikawa; Yuriko Suzuki
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

3.  Evaluation of the pathologic characteristics of excitotoxic spinal cord injury with MR imaging.

Authors:  Sara A Berens; Daniel C Colvin; Chen-Guang Yu; Robert P Yezierski; Thomas H Mareci
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

4.  Development of an inductively coupled MR coil system for imaging and spectroscopic analysis of an implantable bioartificial construct at 11.1 T.

Authors:  Nelly A Volland; Thomas H Mareci; Ioannis Constantinidis; Nicholas E Simpson
Journal:  Magn Reson Med       Date:  2010-04       Impact factor: 4.668

5.  Effect of vascular endothelial growth factor treatment in experimental traumatic spinal cord injury: in vivo longitudinal assessment.

Authors:  Laura M Sundberg; Juan J Herrera; Ponnada A Narayana
Journal:  J Neurotrauma       Date:  2011-03-24       Impact factor: 5.269

6.  Sustained expression of vascular endothelial growth factor and angiopoietin-1 improves blood-spinal cord barrier integrity and functional recovery after spinal cord injury.

Authors:  Juan J Herrera; Laura M Sundberg; Lorena Zentilin; Mauro Giacca; Ponnada A Narayana
Journal:  J Neurotrauma       Date:  2010-10-28       Impact factor: 5.269

7.  High-resolution MR imaging of the rat spinal cord in vivo in a wide-bore magnet at 17.6 Tesla.

Authors:  V C Behr; T Weber; T Neuberger; M Vroemen; N Weidner; U Bogdahn; A Haase; P M Jakob; C Faber
Journal:  MAGMA       Date:  2004-10-23       Impact factor: 2.310

8.  Effect of VEGF treatment on the blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Chirag B Patel; David M Cohen; Pallavi Ahobila-Vajjula; Laura M Sundberg; Tessy Chacko; Ponnada A Narayana
Journal:  J Neurotrauma       Date:  2009-07       Impact factor: 5.269

9.  Blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced MRI.

Authors:  David M Cohen; Chirag B Patel; Pallavi Ahobila-Vajjula; Laura M Sundberg; Tessy Chacko; Shi-Jie Liu; Ponnada A Narayana
Journal:  NMR Biomed       Date:  2009-04       Impact factor: 4.044

10.  Comprehensive small animal imaging strategies on a clinical 3 T dedicated head MR-scanner; adapted methods and sequence protocols in CNS pathologies.

Authors:  Deepu R Pillai; Robin M Heidemann; Praveen Kumar; Nagesh Shanbhag; Titus Lanz; Michael S Dittmar; Beatrice Sandner; Christoph P Beier; Norbert Weidner; Mark W Greenlee; Gerhard Schuierer; Ulrich Bogdahn; Felix Schlachetzki
Journal:  PLoS One       Date:  2011-02-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.